A heart procedure offered at OSF HealthCare will now be able to help more patients, thanks to FDA approval.
The FDA approved Transcatheter Aortic Valve Replacement (TAVR) for intermediate risk patients. TAVR is offered in Peoria only at OSF Saint Francis Medical Center. Previously, TAVR was approved only for heart valve patients deemed at high risk -- those not well enough to undergo open-heart surgery.
TAVR is for patients with severe aortic stenosis, or narrowing of the aortic valve opening. Most patients undergoing the procedure can leave the hospital after one or two days and can resume all normal activities within 10 days of the procedure. Traditional open chest surgery requires seven days of hospitalization and six weeks of rehabilitation.
The TAVR team at OSF Saint Francis Medical Center has performed nearly 250 of the procedures.
“At OSF we go a step beyond, using the minimal approach TAVR (MA-TAVR) method,” Dr. Sudhir Mungee, one of the lead physicians on the Peoria TAVR team, said. “This means a patient comes to a hybrid catheter lab with only a peripheral IV. The TAVR is performed with no general anesthesia or intubation and no surgical incision. A minimal approach TAVR patient is normally up eating dinner that same evening. Imagine a heart valve replacement without open chest, no skin incision and only minimal anesthesia.
“We have patients who have been biking after TAVR. People are traveling, they’re golfing. Their quality of life has improved,” Mungee said. “You don’t have to feel short of breath when you walk to the bathroom. They’ll tell you the next morning, ‘I can breathe.’ That’s how much of a difference TAVR makes, and how quickly that difference is felt.”